<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03473028</url>
  </required_header>
  <id_info>
    <org_study_id>2019</org_study_id>
    <nct_id>NCT03473028</nct_id>
  </id_info>
  <brief_title>Transvaginal Ultrasonography Guided Embryo Transfer</brief_title>
  <official_title>Could Transvaginal Ultrasonography Guided Embryo Transfer Improves Pregnancy Outcome in Obese Patients Undergoing Intracytoplasmic Sperm Inoculation? Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      to evaluate the value of using transvaginal ultrasound guided embryo transfer in obese
      patients undergoing in vitro fertilization.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The 800 participants with body mass index more than 40 kg/m2 were randomly allocated to two
      groups of equal size using an automated web-based randomization system. The first group 400
      patient undergoing the transabdominal-guided embryo transfer, the second group 400 patient
      undergoing transvaginal-guided embryo transfer.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2018</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clinical pregnancy rate`</measure>
    <time_frame>4 weeks following embryo transfer</time_frame>
    <description>the presence of at least one intrauterine gestational sac with viable fetus.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Infertility, Female</condition>
  <arm_group>
    <arm_group_label>transabdominal ultrasound</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>400 obese female undergo transabdominal ultrasound guided embryo transfer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>transvaginal group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>400 obese female undergo transvaginal ultrasound guided embryo transfer</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>transabdominal ultrasound guided embryo transfer</intervention_name>
    <description>400 female with body mass index more than 35 undergo transabdominal ultrasound guided embryo transfer</description>
    <arm_group_label>transabdominal ultrasound</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>transvaginal ultrasound guided embryo transfer</intervention_name>
    <description>400 female with body mass index more than 35 undergo transvaginal ultrasound guided embryo transfer</description>
    <arm_group_label>transvaginal group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI more than 35, good ovarian reserve, unexplained infertility more than 3 years.

        Exclusion Criteria:

          -  severe male factor of infertility,uterine factor of infertility excluded by
             ultrasonography and hysteroscopy ,ovarian endometrioma or patients with poly cystic
             ovary syndrome, obesity caused by abnormal endocrine function (thyroid or adrenal
             disorder)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kasr El Ainiy Hospital</name>
      <address>
        <city>Cairo</city>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2018</study_first_submitted>
  <study_first_submitted_qc>March 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 21, 2018</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>sarah mohamed hassan</investigator_full_name>
    <investigator_title>lecturer of obstetrics and gynecology</investigator_title>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>embryo transfer</keyword>
  <keyword>invitro fertilization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

